MolecularMD Raises $3M

Xconomy Seattle — 

MolecularMD, a Portland, OR-based maker of molecular diagnostic tests for cancer, has raised $3 million in a new round of financing, according to data from VentureDeal. The company was founded in 2006 on technology from Brian Druker and Michael Heinrich at Oregon Health & Science University.

By posting a comment, you agree to our terms and conditions.

Comments are closed.